Toxoplasmose

Maldonado YA, Read JS, Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017 Feb;139(2):e20163860.Texto completo  Resumo

Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - toxoplasmosis. May 2023​ [internet publication].Texto completo

Department of Health and Human Services, Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Sept 2022. [internet publication].Texto completo

Hoz RM La, Morris MI; Infectious Diseases Community of Practice of the American Society of Transplantation. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients - guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep;33(9):e13546. Resumo

Desmonts G. Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Eng J Med. 1974 May 16;290(20):1110-6. Resumo

Department of Health and Human Services, Panel on Opportunistic Infections in Children with and Exposed to HIV. Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV. Aug 2023 [internet publication].​Texto completo

McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006 May 15;42(10):1383-94. Resumo

Pradhan E, Bhandari S, Gilbert RE, et al. Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Database Syst Rev. 2016 May 20;(5):CD002218.Texto completo  Resumo

1. Dubey JP. The life cycle of Toxoplasma gondii. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 1.

2. Rostami A, Riahi SM, Gamble HR, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020 Jun;26(6):673-83.Texto completo  Resumo

3. Jones JL, Kruszon-Moran D, Rivera H, et al. Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014 Jun;90(6):1135-9. Resumo

4. Jones JL, Kruszon-Moran D, Elder S, et al. Toxoplasma gondii infection in the United States, 2011-2014. Am J Trop Med Hyg. 2018 Feb;98(2):551-7.Texto completo  Resumo

5. Nogareda F, Le Strat Y, Villena I, et al. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation. Epidemiol Infect. 2014 Aug;142(8):1661-70.Texto completo  Resumo

6. Petersen E. Epidemiology, diagnostics, and chemotherapy. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 3.

7. Mirinaviciute G, Barlinn R, Gjeruldsen Dudman S, et al. Immunity to varicella zoster virus among pregnant women in the Norwegian mother and child cohort study PLoS One. 2019 Aug 13;14(8):e0221084.Texto completo  Resumo

8. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013 Jul 1;91(7):501-8.Texto completo  Resumo

9. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004 Jun 12;363(9425):1965-76. Resumo

10. Maldonado YA, Read JS, Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017 Feb;139(2):e20163860.Texto completo  Resumo

11. Howe D, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995 Dec;172(6):1561-6. Resumo

12. Zhou P, Zhang H, Lin RQ, et al. Genetic characterization of Toxoplasma gondii isolates from China. Parasitol Int. 2009 Jun;58(2):193-5. Resumo

13. Ferreira Ade M, Vitor RW, Gazzinelli RT, et al. Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP. Infect Genet Evol. 2006 Jan;6(1):22-31. Resumo

14. Boughattas S, Ben-Abdallah R, Siala E, et al. Direct genotypic characterization of Toxoplasma gondii strains associated with congenital toxoplasmosis in Tunisia (North Africa). Am J Trop Med Hyg. 2010 Jun;82(6):1041-6. Resumo

15. Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009 Sep 15;49(6):878-84. Resumo

16. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 1998 Apr;11(2):267-99.Texto completo  Resumo

17. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - toxoplasmosis. May 2023​ [internet publication].Texto completo

18. Wilson CB, Remington JS, Stagno S, et al. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767-74. Resumo

19. Campbell AL, Goldberg CL, Magid MS, et al. First case of toxoplasmosis following small bowel transplantation and systematic review of tissue-invasive toxoplasmosis following noncardiac solid organ transplantation. Transplantation. 2006 Feb 15;81(3):408-17. Resumo

20. Goldszmid RS, Bafica A, Jankovic D, et al. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J Exp Med. 2007 Oct 29;204(11):2591-602.Texto completo  Resumo

21. Liu CH, Fan YT, Dias A, et al. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol. 2006 Jul 1;177(1):31-5.Texto completo  Resumo

22. Perona-Wright G, Mohrs K, Szaba FM, et al. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe. 2009 Dec 17;6(6):503-12.Texto completo  Resumo

23. Hunter CA, Lieberman LA, Mason N, et al. Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma. Immunol Res. 2003;27(2-3):331-40. Resumo

24. Adams LB, Hibbs JB Jr, Taintor RR, et al. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990 Apr 1;144(7):2725-9. Resumo

25. Department of Health and Human Services, Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Sept 2022. [internet publication].Texto completo

26. Hoz RM La, Morris MI; Infectious Diseases Community of Practice of the American Society of Transplantation. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients - guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep;33(9):e13546. Resumo

27. Martino R, Bretagne S, Einsele H, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis. 2005 Jan 1;40(1):67-78.Texto completo  Resumo

28. Kim K. Toxoplasmosis. In: Conn's current therapy, Rakel RE, ed. Philadelphia, PA: WB Saunders; 2000:151-57.

29. Desmonts G. Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Eng J Med. 1974 May 16;290(20):1110-6. Resumo

30. Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet. 1999 May 29;353(9167):1829-33. Resumo

31. Pfaff AW, Liesenfeld O, Candolfi E. Congenital toxoplasmosis. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 5.

32. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Infectious diseases of the fetus and newborn infant. JS Remington, JO Klein, eds. Philadelphia, PA: WB Saunders; 1995:chapter 5.

33. Chapey E, Wallon M, Debize G, et al. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J Clin Microbiol. 2010 Jan;48(1):41-5.Texto completo  Resumo

34. Hoffmann C, Ernst M, Meyer P, et al. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses. Clin Microbiol Infect. 2007 May;13(5):510-5.Texto completo  Resumo

35. Palanisamy M, Madhavan B, Balasundaram MB, et al. Outbreak of ocular toxoplasmosis in Coimbatore, India. Indian J Ophthalmol. 2006 Jun;54(2):129-31.Texto completo  Resumo

36. Boyer KM, Remington JS, McLeod R. Toxoplasmosis. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD, Demmler GJ, et al, eds. Philadelphia, PA: Saunders; 2004:chapter 222.

37. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol. 2004 Mar;42(3):941-5.Texto completo  Resumo

38. Cinque P, Scarpellini P, Vago L, et al. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS. 1997 Jan;11(1):1-17. Resumo

39. Robert-Gangneux F, Sterkers Y, Yera H, et al. Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study. J Clin Microbiol. 2015 May;53(5):1677-84. Resumo

40. Thompson MA, Horberg MA, Agwu AL, et al. Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2020 Nov 6;ciaa1391.Texto completo  Resumo

41. Zufferey J, Sugar A, Rudaz P, et al. Prevalence of latent toxoplasmosis and serologic diagnosis of active infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):591-5. Resumo

42. Zangerle R, Allerberger F, Pohl P, et al. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol. 1991;180(2):59-66. Resumo

43. US Department of Health and Human Services, Organ Procurement and Transplantation Network; United Network for Organ Sharing. Position statement: improving post-transplant communication of new donor information. Mar 2016 [internet publication].Texto completo

44. Derouin F, Pelloux H, ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008 Dec;14(12):1089-101.Texto completo  Resumo

45. American College of Obstetricians and Gynecologists. ACOG guidelines at a glance: key points about 4 perinatal infections. Dec 2015 [internet publication].Texto completo

46. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med. 1994 Jun 30;330(26):1858-63. Resumo

47. Department of Health and Human Services, Panel on Opportunistic Infections in Children with and Exposed to HIV. Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV. Aug 2023 [internet publication].​Texto completo

48. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 1988 Feb 4;318(5):271-5. Resumo

49. Peyron F, L'ollivier C, Mandelbrot L, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French Multidisciplinary Working Group. Pathogens. 2019 Feb 18;8(1):24.Texto completo  Resumo

50. Mandelbrot L, Kieffer F, Sitta R, et al. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol. 2018 Oct;219(4):386.e1-386.e9. Resumo

51. Khalil A, Sotiriadis A, Chaoui R, et al. ISUOG practice guidelines: role of ultrasound in congenital infection. Ultrasound Obstet Gynecol. 2020 Jul;56(1):128-51.Texto completo  Resumo

52. Brown ED, Chau JK, Atashband S, et al. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2009 May;73(5):707-11. Resumo

53. McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006 May 15;42(10):1383-94. Resumo

54. Roberts F, Kuo A, Jones L, et al. Ocular toxoplasmosis: clinical features, pathology, pathogenesis, animal models, and immune responses. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 4.

55. Pradhan E, Bhandari S, Gilbert RE, et al. Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Database Syst Rev. 2016 May 20;(5):CD002218.Texto completo  Resumo

56. Jasper S, Vedula SS, John SS, et al. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Database Syst Rev. 2017 Jan 26;(1):CD007417.Texto completo  Resumo

57. Stanford MR, See SE, Jones LV, et al. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology. 2003 May;110(5):926-31;quiz 931-2. Resumo

58. Silveira C, Belfort R, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002 Jul;134(1):41-6. Resumo

59. Kim SJ, Scott IU, Brown GC, et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013 Feb;120(2):371-8. Resumo

60. Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005 Nov;112(11):1876-82. Resumo

61. Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina. 2007 Sep;27(7):952-7. Resumo

62. Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002 Jul;134(1):34-40. Resumo

63. Baharivand N, Mahdavifard A, Fouladi RF, et al. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial. Int Ophthalmol. 2013 Feb;33(1):39-46. Resumo

64. Felix JP, Lira RP, Zacchia RS, et al. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Am J Ophthalmol. 2014 Apr;157(4):762-66;e1. Resumo

65. Wallon M, Peyron F, Cornu C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013 May;56(9):1223-31. Resumo